*Department of Pathology, Peking University Shenzhen Hospital
†State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School
§Department of Pathology, Shenzhen Nanshan People’s Hospital
¶Department of Pathology, Shenzhen People’s Hospital, Jinan University Second Clinical Medical College, Shenzhen, Guangdong Province
‡Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan Province
∥Department of Pathology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, Fujian Province, China
Supported by grants from Shenzhen Health System Research Project (No. SZFZ2018074, J.L.), Open Research Fund of State Key Laboratory of Chemical Oncogenomics in 2018 (J.L.), and “San-ming” Project of Medicine in Shenzhen (No. SZSM20182088, W.Y.), Research Foundation of Peking University Shenzhen Hospital (No. JCYJ2018001, J.L.). The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Weihua Yin, MD, Department of Pathology, Peking University Shenzhen Hospital, Lianhua Road, Futian District, Shenzhen 518036, Guangdong Province, China (e-mail: [email protected]).